With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia||Boston Children's Hospital / Chun-Chin Chen, PhD||Young Investigator Grants||2023||Massachusetts|
|Targeting Oncogenic N-MYC Complexes in High-Risk Neuroblastoma||The Regents of the University of California San Francisco / Bo Qiu, MD/PhD||Young Investigator Grants||2023||California|
|Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS||St. Jude Children's Research Hospital / Dirk Loeffler, PhD||RUNX1 Early Career Investigator Grants||2023||Tennessee|
|Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity||Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD||Young Investigator Grants||2023||Ohio|
|Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs||Broad Institute / Sean Misek, PhD||Young Investigator Grants||2023||Massachusetts|
|Targeting the biological underpinnings of pulmonary metastasis in osteosarcoma||Dana-Farber Cancer Institute / Rani George, MD/PhD||Crazy 8 Awards||2022||Massachusetts|
|GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma||Baylor College of Medicine / Kyle Eagen, PhD||R Accelerated Award Grants||2022||Texas|
|Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL||Temple University / Christian Hurtz, PhD||'A' Award Grants||2022||Pennsylvania|
|Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations||The Regents of the University of Michigan / Jolanta Grembecka, PhD||Reach Grants||2022||Michigan|
|Inhibition of translation initiation as a novel therapeutic strategy against MYCN-amplified neuroblastoma||Dana-Farber Cancer Institute / Rani George, MD, PhD||Innovation Grants||2022||Massachusetts|